[1]
Gamage, K. et al. 2022. SUCCESSFUL USE OF RITUXIMAB TO TREAT GLUCOCORTICOID RESISTANT LYMPHOPLASMACYTIC HYPOPHYSITIS: A CASE REPORT. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 76. DOI:https://doi.org/10.15605/jafes.037.AFES.119.